VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650 | +33.7% | 150,399 | +103.7% | 0.01% | +50.0% |
| Q2 2023 | $486 | -99.5% | 73,822 | +631.0% | 0.00% | +300.0% |
| Q3 2022 | $100,000 | -93.4% | 10,099 | -92.7% | 0.00% | -94.4% |
| Q2 2022 | $1,506,000 | +82.1% | 138,176 | +88.9% | 0.02% | +80.0% |
| Q1 2022 | $827,000 | +17.6% | 73,131 | +63.2% | 0.01% | +42.9% |
| Q4 2021 | $703,000 | +92.1% | 44,815 | +163.1% | 0.01% | +75.0% |
| Q2 2021 | $366,000 | -55.2% | 17,034 | -68.7% | 0.00% | -66.7% |
| Q1 2021 | $817,000 | +383.4% | 54,402 | +322.1% | 0.01% | +500.0% |
| Q4 2020 | $169,000 | -61.9% | 12,887 | -52.2% | 0.00% | -75.0% |
| Q4 2019 | $443,000 | – | 26,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |